eclinical software

Trials are getting complicated. IQVIA shows big jumps in procedures, endpoints, and data over 20 years. With wearables and multi-site labs, teams now handle many more data sources. Old, separate systems can’t keep up. When EDC, RTSM, and compliance run in different directions, people end up fixing records by hand. That wastes hours, creates errors, and delays the database lock. To solve this, forward-thinking drug developers are moving away from patched-together stacks and toward an integrated eclinical platform. Bringing site operations, patient data, and compliance into a single system eliminates manual handoffs, provides immediate cross-team visibility, and improves ROI. The Economic Realities Driving Unified Technology Buying and managing many point solutions leaks money at every stage of a study. That’s driving vendor consolidation across the industry. Analysts forecast the eclinical market to be worth nearly $13.1 billion, with integrated platforms taking the lion…